Drug archive
Gemcitabine (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antineoplastic
Description
Gemcitabine (jem-SITE-a-been) belongs to the group of medicines called antimetabolites. It is used to treat cancer of the pancreas and lung. It may also be used to treat other kinds of cancer, as determined by your doctor.
Gemcitabine interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal cells may also be affected by the medicine, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern. Some effects may occur after treatment with gemcitabine has been stopped.
This medicine is available only with your doctor's prescription, in the following dosage form:
- Injection (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Gemzar
In Canada -
- Gemzar